Yang JC, Janssen EM, Wallace MJ, Sheahan A, et al. Quantifying Patient Preferences for Risk Tolerance With Novel Dual Biologic Therapies for Inflammatory Bowel Disease. Am J Gastroenterol 2025 Mar 6. doi: 10.14309/ajg.0000000000003397.
PMID: 40243385